The availability of services is highly sensitive to changes in both supply and demand. On the supply side, the availability of evidence-based treatments (
27,
28) increases the cost-effectiveness of care. On the demand side, federal policies such as the State Children’s Health Insurance Program (SCHIP), which began in 1997, may increase demand (
29), whereas the recent increase in the number of uninsured Americans may reduce demand. Thus studies measuring supply of and demand for mental health services need to have a fairly short time line to capture the current service environment.
Unlike adults, children may receive mental health services from many agencies whose primary responsibilities do not include mental health care. In addition to specialty mental health providers and primary care providers, who may or may not have mental health training, schools, juvenile justice agencies, and human services agencies are frequently mandated to provide such services. A recent analysis of data from the National Comorbidity Survey Adolescent Supplement (NCS-A) presented lifetime rates of disorder-specific service use for a representative national sample of adolescents (
30). The study reported here used the same data set to derive information on how various service sectors provided services for various types of disorder within a 12-month period. The goal of the analysis was to increase comparability with earlier studies, where lifetime data are scarce (
31–
34).
Results
Table 1 presents data for youths who received any services for psychiatric disorders in the past 12 months, by service setting and diagnosis. Of those with any diagnosis, 45.0% reported receiving any treatment from any source. The probability of treatment was associated with number of disorders: 68.7% of those with three or more disorders received treatment, compared with 44.0% of those with two disorders, 31.9% of those with one disorder, and 14.4% of those with no diagnosis.
Among individuals with mental disorders, the most likely to have received any treatment in the past 12 months were those with ADHD (73.8%), conduct disorder (73.4%), or oppositional defiant disorder (71.0%). Least likely to have received treatment were individuals with specific phobias (40.7%) and any anxiety disorder (41.4%).
Sources of services
Adolescents with any psychiatric disorder were most likely to receive services in schools (23.6%) and specialty mental health settings (22.8%). Youths with ADHD were more likely to get treatment in schools (54.5%) than in specialty mental health settings (37.3%), whereas the opposite was true for those with eating disorders (schools, 20.9%; specialty settings, 43.0%) and drug use disorders (schools, 32.9%; specialty settings, 44.4%).
A smaller proportion of youths with recent psychiatric disorders received services from general medical providers (primary care pediatricians and other primary care providers) (10.1%). As
Table 1 shows, the largest proportions of youths receiving services for psychiatric disorders from general medical providers had major depressive disorder (17.6%) or ADHD (17.3%). However, taking into account the numbers of youths with various disorders, general medical providers were almost twice as likely to see adolescents with an impulse control disorder (11.5% of 1,465, or 165 youths) as adolescents with major depressive disorder (17.6% of 544, or 95 youths) or ADHD (17.3% of 408, or 71 youths).
Correlates of service use
Table 2 presents the sociodemographic correlates of service receipt in one or more of the service sectors by youths with a diagnosis. Males with a diagnosis were more likely than females to have received any services in the past 12 months, but the difference was significant only for juvenile justice and school services. The only other factor associated with increased use of any services was living in a household with other than two biological parents. These youths were more likely to receive specialty mental health services and juvenile justice services.
Services that might entail cost to families, such as specialty mental health services, general medical services, and CAM, were more sensitive to sociodemographic markers. For example, parents with some college were more likely to seek specialty mental health care for their children. On the other hand, youths from poorer families were more likely than those in the wealthiest segment to receive services from the juvenile justice system. In specialty mental health settings, non-Hispanic black adolescents were less likely than white youths to receive care for psychiatric disorders. Receipt of care for psychiatric disorders in school settings was highest in the states in the South, while use of CAM services was significantly lower there.
Discussion
This analysis of service use for psychiatric disorders by adolescents in the past 12 months in a nationally representative sample confirms earlier findings that only a subset of youths with psychiatric disorders receives treatment of any sort. Moreover, much of this treatment was provided in service settings in which few providers were likely to have specialist mental health training. Fewer than half of youths with any disorder in the past 12 months received any services, and fewer than one in four received specialty mental health services. Even among those with three or more disorders, fewer than half had recently received any specialty mental health care.
This rate is slightly but not dramatically higher than that found ten years earlier in the Great Smoky Mountains Study, in which 21.6% of youths with serious and impairing mental illnesses received specialty mental health care (
10). The 2001–2004 National Health and Nutrition Examination Study found a much higher rate of 12-month mental health service use (52.8%), but that study did not clarify which service sector was used (
37).
The findings are consistent with those of earlier and more geographically constrained studies (
6,
7,
10), suggesting that nothing much has changed in the decades since the first U.S. studies of service use for psychiatric disorders, despite the spread of evidence-based treatments and the increase in the number of youths eligible for public health insurance through SCHIP. For example, Burns and colleagues (
10) found that 21.6% of a slightly younger sample (
9–
13) with serious diagnoses had received specialty mental health care in the past three months, and Offord and colleagues (
41) reported that 18.1% of boys and 13.5% of girls in Canada with a psychiatric diagnosis had received care from specialty mental health services or social services in the past six months.
The findings reported here, which have a 12-month time frame, provide a more appropriate comparison with these studies than does our previous report on lifetime service use (
30). There are two reasons for this. First, there are no comparable studies of lifetime service use in this age range. Second, the lifetime prevalence of mental health specialty service use for any psychiatric disorder was 46.5% (
30); comparison with the rate of 22.8% reported here suggests a considerable degree of forgetting or underreporting in the previous study.
We noted some interesting distinctions among race, income, and parent education as correlates of service use. Youths with a disorder from white, more educated families were more likely to find their way into specialty mental health or CAM services, whereas poverty was associated with service receipt from schools and the juvenile justice system. Living in a family with other than two biological parents, on the other hand, was associated with both juvenile justice and specialty mental health service use.
Among all adolescents with a psychiatric disorder, general medical practitioners saw about one in ten. General medical practitioners may well be competent to care for youths with some psychiatric disorders for which there are evidence-based treatments. However, more than half the youths in the study who had a diagnosis had two or even three disorders, and it is disturbing that so many of these youths with complex conditions may lack access to specialty mental health care.
In the National Comorbidity Study–Replication, which examined data from a representative sample of persons age 18 and older, “the proportion of cases in treatment ranged from a high for dysthymia to a low for intermittent explosive disorder” (
42). In contrast, in the study reported here the proportion of adolescents in treatment ranged from a high for ADHD and conduct disorders to a low for specific phobia. It appears that young people are more likely to have treatment imposed upon them by parents and others in authority for “externalizing,” trouble-making disorders, whereas adults are most likely to seek treatment themselves for “internalizing” conditions such as depression. This underlines the importance, when evaluating patterns of health care utilization, of considering not just available treatments but also how individuals get into care (
43).
Another difference between adults and adolescents is that 85.5% of adults in treatment were seen in the health care sector—most in general medical settings (52.0% of those in treatment) (
42). In contrast, among the 45.0% of adolescents with any disorder who received any care in this study, 10.1% obtained care in the general medical sector, compared with 23.6% in schools. Many of the persons listed by participants as providing help with adolescents’ emotional or behavioral problems were identified as pediatricians, school counselors, or probation officers. It is difficult to avoid the conclusion that 20 years after the early studies (
1–
25), many adolescents with disorders amenable to psychiatric treatments still do not have access to specialist care.
This study also identified sociodemographic correlates of service use, among youths with a
DSM-IV disorder (
Table 2). Males and youths closer to the poverty line were more likely to get treatment from juvenile justice or school providers. White youths and those with the most educated parents were more likely to receive either services in mental health specialty settings or CAM services. The fact that no significant differences were found in utilization of specialty mental health and general medical services as a function of income suggests that, as found in other studies, private health insurance gives little benefit when it comes to children’s access to needed mental health care; only public insurance significantly increases access (
13,
44,
45).
Although this study had by far the most representative and largest sample of adolescents, comparisons with previous reports are difficult because of the restricted age range of the NCS-A sample (
13–
17). The overall prevalence of disorders in the past 12 months in the NCS-A (25.5%) is just within the interquartile range of the studies reported in a recent review (14.8%−25.5%) (
26). The other recent, nationally representative study, the National Health and Nutrition Examination Survey of 2001–2004, which used a slightly more limited range of diagnoses, found lower rates of reported service use for each psychiatric disorder (
37). However, that survey asked the following question: “In the past year, have you been to see someone at a hospital or a clinic or at their office [for specific symptoms of disorders]?” This question implicitly excludes systems, such as CAM, juvenile justice, and human services, that provide a large proportion of adolescent mental health care.
It is possible that some of the participants had received services in the year before the study period but that the treatment had not resolved the problem; alternatively, many of those with a disorder may not have yet found their way to a service provider (
26). However, other analyses of the same data set found that lifetime use of services, even among adolescents with severe disorders, was less than 50% (
30).
As noted, it is difficult to interpret access to care in service sectors rationed by health insurance without information about insurance status, including SCHIP, which this study lacked. The NCS-A contains extensive measures of intensity and appropriateness of treatment that will be examined in other analyses. This was a cross-sectional study, and it was not possible to track adolescents’ service use over time or to test whether some services served as “gateways” to others (
22).
Acknowledgments and disclosures
The NCS-A was supported by the National Institute of Mental Health (NIMH) (grants U01-MH60220, R01-MH66627, and U01-MH060220-09S), with supplemental support from the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (grant 044780), and the John W. Alden Trust. The NCS-A is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. This study was supported by NIDA (grants U01-DA024413, DA011301, and DA022308), NIMH (grant MH083964), and the NIMH Intramural Research Program. The authors thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation and field work and consultation on data analysis. The sponsors had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript. The views and opinions expressed are those of the authors and should not be construed to represent the views of any of the sponsoring organizations or agencies or the U.S. government.
Dr. Kessler has been a consultant to, served on advisory boards for, or received research support from Analysis Group, Appliance Computing II, AstraZeneca, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, EPI-Q, GlaxoSmithKline Inc., HealthCore Inc., Health Dialog, Integrated Benefits Institute, John Snow Inc., Johnson & Johnson Pharmaceuticals, Kaiser Permanente, Matria Inc., Mensante, Merck & Co, Inc., Mindsite, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc., Primary Care Network, Research Triangle Institute, Sanofi-Aventis Groupe, Shire U.S., Inc., SRA International, Inc., Takeda Global Research & Development, Transcept Pharmaceuticals Inc., and Wyeth-Ayerst. The other authors report no competing interests.